This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by SCOTT, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCOTT, J.
The British Journal of Psychiatry (2001) 178: s164-s168
© 2001 The Royal College of Psychiatrists

Cognitive therapy as an adjunct to medication in bipolar disorder

JAN SCOTT, FRCPsych

Division of Psychiatry, University Department of Psychological Medicine, Gartnavel Royal Hospital, Glasgow, UK

Correspondence: Professor Jan Scott, Division of Psychiatry, University Department of Psychological Medicine, Gartnavel Royal Hospital, Glasgow G12 0XH, UK. Tel: +44 (0) 141 211 3937; fax: +44 (0) 141 357 4899; e-mail: jan.scott{at}clinmed.gla.ac.uk

Declaration of interest J.S. is the Principal Investigator of a multicentre trial of cognitive therapy for bipolar disorders funded by the Medical Research Council.

Background There is increasing support for the use of cognitive behaviour therapy as an adjunct to medication for patients with bipolar disorder.

Aims To explore current psychological models of bipolar disorder, describing the clinical rationale for using cognitive therapy and providing a brief overview of the approach.

Method Results from outcome studies are discussed.

Results Preliminary findings indicate that cognitive therapy may be beneficial for patients with bipolar disorder. The collaborative, educational style of cognitive therapy, the use of a stepwise approach and of guided discovery is particularly suitable for patients who wish to take an equal and active role in their therapy.

Conclusions Randomised, controlled trials of cognitive therapy in bipolar disorder are required to establish the short-term and long-term benefits of therapy, and whether any reported health gain exceeds that of treatment as usual.